JAK2 inhibition led to significantly reduced tyrosine phosphorylation of STAT3 and markedly reduced cystic growth of human and mouse ADPKD-derived cells in cystogenesis assays. This evidence concerns the gene STAT3 and autosomal dominant polycystic kidney disease.